Exenatide treatment led to the augmented activation of proteins involved in insulin signaling in the brain and of effectors, such as Akt and mTOR
"This new data makes it clear they are a starting point, not a cure," said Garron Dodd, a metabolic neuroscience researcher at the University of Melbourne, not involved in the study
doi: 10.3389/fendo.2021.645563
If the underlying dietary patterns have not changed, and if you cannot afford to continue the medication long-term, the weight lost is likely to return, and potentially with additional muscle loss, making the situation worse than before
Atrium can help patients prepare by documenting BMI, weight-related conditions, prior treatment history, medication tolerance, labs, and the clinical reason a GLP-1 is being considered
In the realm of clinical immunology, the role of prebiotics in managing mast cell activation is gaining significant traction